National Health Research Institutes, Taiwan: all 127 studies

Page 1 of 2. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.

• NHRI Intelligent Voice Interactive Platform for High-Quality Community Living Among Older AdultsRecruitingNCT07855874Not applicable
• The Validation of ICBT Clinical Trial: Disease Stress Adjustment in Breast Cancer PatientsNot yet recruitingNCT07835698Not applicable
• Liposomal Irinotecan Plus Cisplatin in Patients With Advanced or Metastatic Solid MalignanciesNot yet recruitingNCT07782346Phase 1
• Assistive Device Rental/Purchase, LTC Service Use, and Caregiver Burden in TaiwanNot yet recruitingNCT07782047
• Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy DeviceNot yet recruitingNCT07764107Not applicable
• Quantitative Monitoring of Disability Care Quality for Long-Term Care Facilities 2RecruitingNCT07579832Not applicable
• Adult Disease Risk Prediction Using Wearables, Hearing, and Health DataRecruitingNCT07541547
• Social Prescribing Intervention for Health Promotion in Community-Dwelling Older AdultsRecruitingNCT07540117Not applicable
• Precision Vibration Therapy for Neuromuscular and Functional Improvement in Older Adults and Stroke SurvivorsRecruitingNCT07351877Not applicable
• Chronic Wounds and Blood Circulation DetectionRecruitingNCT07330635Not applicable
• Effects of Mindfulness or Brain Stimulation Intervention for Late-life Adults in Taiwan Urban and Rural AreasRecruitingNCT07186023Not applicable
• Internet-Based Cognitive Behavioral Therapy With Treatment as Usual for Generalized Anxiety Disorder and Major Depressive Disorder in Taiwan (ICBT-TW)Not yet recruitingNCT07177365Not applicable
• Plant-based Diets and Healthy AgingRecruitingNCT07151365
• Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination TherapyNot yet recruitingNCT07151326Phase 2
• Taiwanese Anaplastic Thyroid Cancer RegistryNot yet recruitingNCT07138261
• Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)RecruitingNCT06981637Phase 2
• The Registry Study of Genetic Alterations of Melanoma in TaiwanRecruitingNCT06952400
• Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)RecruitingNCT06271200Not applicable
• The Registry of Genetic Alterations of Taiwan Ovarian CancerRecruitingNCT06127446
• Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .RecruitingNCT05927857Phase 1/2
• Genomics and Prognosis in GI CancersRecruitingNCT05767697
• Neoantigen Derived DCs as Cancer TreatmentRecruitingNCT05767684Phase 1
• A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse GliomaRecruitingNCT05622409
• The Registry Study of Genetic Alterations of Oropharyngeal Cancer in TaiwanRecruitingNCT05522881
• Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NETEnrolling by invitationNCT05385861Phase 1/2
• Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine TumorsRecruitingNCT05048901Phase 1/2
• Peri-operative SLOG for Localized Pancreatic CancerRecruitingNCT05048524Phase 2
• A Phase I/II Study of Diffuse Large B-cell LymphomaNot yet recruitingNCT04856137Phase 1/2
• The Research Plan of Taiwan Precision MedicineRecruitingNCT04849481
• A Single-dose Phase 1 Study of DBPR108 in Healthy Male SubjectsCompletedNCT01650324Phase 1Results posted
• Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.WithdrawnNCT07369791Phase 2
• The Effects of a Meditation Intervention on the Psychological Burden of Long-Term Care Professionals and Family CaregiversCompletedNCT07188454Not applicable
• The Registry of Genetic Expression of Taiwan Urologic CancerActive, not recruitingNCT05725304
• Outcome of GI Cancer in NCKUHCompletedNCT05700188
• Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral EtiologiesActive, not recruitingNCT05613621
• A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)Active, not recruitingNCT05541380
• Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based TreatmentActive, not recruitingNCT05170438Phase 2
• Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell LymphomasTerminatedNCT05105412Phase 1/2
• The Registry of Genetic Alterations of Taiwan Biliary Tract CancerActive, not recruitingNCT05036486
• A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic CancerActive, not recruitingNCT05026905Phase 2
• The Registry Study of Genetic Alterations of Esophageal Cancer in TaiwanActive, not recruitingNCT04996095
• BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)CompletedNCT04839471Phase 2
• Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor PatientsActive, not recruitingNCT04821895
• Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma.CompletedNCT04688151Phase 1
• Home-based Longitudinal Investigation of the Multidisciplinary Team Integrated CareStatus unknownNCT04250103
• Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment ModelStatus unknownNCT04203654Not applicable
• Atezolizumab Plus Bevacizumab With HCC and HBV InfectionActive, not recruitingNCT04180072Not applicable
• NGS as the First-line Treatment in Advanced Biliary Tract CancerCompletedNCT04172402Phase 2
• Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or ChemoradiotherapyCompletedNCT03712397Phase 2
• Observational Registry Data on GIST PatientsCompletedNCT03602092
• Locally Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT03559348Phase 2
• Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNATerminatedNCT03544099Phase 2
• Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)CompletedNCT03510871Phase 2
• Vegetable Signature From Human Metabolomics ResponsesCompletedNCT03483558Not applicable
• Blood Pressure Control for Type 2 DiabetesStatus unknownNCT03477786Not applicable
• SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic CancerCompletedNCT03443492Phase 2
• Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT03406299Phase 2
• The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab TreatmentStatus unknownNCT03401957
• A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung CancerTerminatedNCT03246854Phase 1
• Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary CancersCompletedNCT03162510Phase 1
• National Health Interview Survey in TaiwanCompletedNCT02843360
• Healthy Aging Longitudinal Study in TaiwanStatus unknownNCT02677831
• Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia PatientsCompletedNCT02553304
• Methadone Maintenance Outcome Study in Taiwan: 5-year Follow-upStatus unknownNCT02524912
• Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas PatientsCompletedNCT02457273Phase 2
• First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCLStatus unknownNCT02388581Phase 2
• A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar CholangiocarcinomaTerminatedNCT02374489Phase 2
• A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNATerminatedNCT02363400Phase 3
• A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male SubjectsCompletedNCT02163278Phase 1
• Gastroenteral-Pancreatic Neuroendocrine Tumors in TaiwanCompletedNCT02102893
• A Phase II Study of Locally Advanced Pancreatic CancerStatus unknownNCT01867892Phase 2
• Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission PatientsCompletedNCT01744587Not applicable
• Decision Making Deficit and DNA Methylation in Opioid Receptor Genes Among Community Heroin AddictsStatus unknownNCT01668732
• Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid AddictsCompletedNCT01668706
• Biomarkers Study in Pancreatic CancerStatus unknownNCT01666184
• Establish a Vegetable Signature Database From Human Metabolomics ResponsesStatus unknownNCT01600911Not applicable
• Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma StudyTerminatedNCT01558011Phase 2
• The Study of Metastatic Pancreatic AdenocarcinomaCompletedNCT01415713Phase 1/2
• A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) PatientsStatus unknownNCT01389583Phase 2
• Blood Pressure and Glucose Lowering Diet for TaiwaneseStatus unknownNCT01364337Not applicable
• A Study to Evaluate the Safety and Immunogenicity of EV71 VaccineCompletedNCT01268787Phase 1
• A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTCCompletedNCT01267344Phase 2
• Sorafenib Plus S-1 in Advanced Solid TumorsCompletedNCT01128998Phase 1
• Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic PatientsCompletedNCT01105481Phase 4
• Methadone Maintenance Treatment Outcome Study in TaiwanStatus unknownNCT01093248
• A Study of Locally Advanced Pancreatic CancerStatus unknownNCT01063192Phase 2
• Therapeutic Drug Monitoring and Pharmacogenomics Study of Methadone TherapyStatus unknownNCT01059747
• A Phase III Study of Pancreatic CancerCompletedNCT00994721
• Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)TerminatedNCT00971126Phase 1/2
• A Study of High-Risk Oral Cavity CancerTerminatedNCT00934739Phase 2/3
• A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell CarcinomaCompletedNCT00933387Phase 2
• Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma PatientsStatus unknownNCT00931229Not applicable
• Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal CancerCompletedNCT00931203Phase 2
• An Interventional Study of Geriatric Frailty, Osteoporosis, and DepressionCompletedNCT00718432Not applicable
• SAPPHIRe III in Taiwan-Progression Evaluation and Cardiovascular Outcomes of Hypertensive FamiliesStatus unknownNCT00631956
• a Phase II Study in Primary Central Nervous System LymphomaStatus unknownNCT00455286Phase 2
• A Phase III Study in Post-operative HBV-related Hepatocellular CarcinomaTerminatedNCT00455091
• Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00390195Phase 1/2
• Clinical Pharmacogenomics of Antidepressant ResponseCompletedNCT00384020
• Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GISTCompletedNCT00359333Phase 2

← National Health Research Institutes, Taiwan overview and focus areas